Simplex Trading’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.66K Sell
200
-3,300
-94% -$34.2K ﹤0.01% 8443
2025
Q4
$43.3K Buy
3,500
+1,600
+84% +$17.1K ﹤0.01% 5793
2025
Q3
$16K Sell
1,900
-6,600
-78% -$51.3K ﹤0.01% 7524
2025
Q2
$54K Sell
8,500
-10,900
-56% -$62.4K ﹤0.01% 5849
2025
Q1
$94K Sell
19,400
-6,300
-25% -$52.1K ﹤0.01% 5113
2024
Q4
$245K Sell
25,700
-9,700
-27% -$89K 0.01% 4299
2024
Q3
$295K Sell
35,400
-3,800
-10% -$34.5K 0.01% 4149
2024
Q2
$267K Buy
39,200
+5,100
+15% +$21.9K 0.01% 4355
2024
Q1
$86K Sell
34,100
-7,900
-19% -$17.8K ﹤0.01% 5742
2023
Q4
$100K Buy
42,000
+21,800
+108% +$51.2K ﹤0.01% 5382
2023
Q3
$68K Sell
20,200
-26,300
-57% -$146K ﹤0.01% 5504
2023
Q2
$341K Buy
46,500
+40,400
+662% +$375K 0.01% 3696
2023
Q1
$63K Buy
6,100
+5,000
+455% +$60.4K ﹤0.01% 5656
2022
Q4
$12K Sell
1,100
-11,100
-91% -$172K ﹤0.01% 7356
2022
Q3
$256K Buy
12,200
+6,000
+97% +$167K 0.01% 4278
2022
Q2
$192K Buy
6,200
+3,700
+148% +$126K 0.01% 4662
2022
Q1
$102K Sell
2,500
-2,300
-48% -$101K ﹤0.01% 6110
2021
Q4
$208K Sell
4,800
-400
-8% -$18.1K 0.01% 5131
2021
Q3
$332K Hold
5,200
0.01% 4737
2021
Q2
$327K Buy
5,200
+5,129
+7,224% +$330K 0.01% 4831
2021
Q1
$659K Buy
+71
New +$7.27K 0.04% 2959
2020
Q4
Sell
-17
Closed -$175K 8676
2020
Q3
$175K Sell
17
-16
-48% -$1.73K 0.01% 4284
2020
Q2
$260K Sell
33
-4
-11% -$298 0.01% 3690
2020
Q1
$214K Buy
37
+32
+640% +$1.84K 0.01% 3512
2019
Q4
$26K Sell
5
-3
-38% -$163 ﹤0.01% 5751
2019
Q3
$41K Sell
8
-1
-11% -$47 ﹤0.01% 5201
2019
Q2
$43K Hold
9
﹤0.01% 4997
2019
Q1
$45K Buy
+9
New +$531 ﹤0.01% 5089
2017
Q1
Sell
-45
Closed -$9K 6453
2016
Q4
$9K Sell
45
-11
-20% -$330 ﹤0.01% 3831
2016
Q3
$20K Buy
56
+4
+8% +$116 ﹤0.01% 2960
2016
Q2
$28K Sell
52
-93
-64% -$3.65K ﹤0.01% 2582
2016
Q1
$8K Buy
+145
New +$5.12K ﹤0.01% 3666
2015
Q4
Sell
-20
Closed -$7K 5692
2015
Q3
$7K Buy
+20
New +$659 ﹤0.01% 3722

Other funds holding EBS